StonvexLoading…
StonvexStonvexStonvexCore line items from DXPE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.02B | $1.80B | $1.68B | $1.48B |
Operating Income | $176.87M | $145.38M | $138.72M | $97.75M |
Net Income | $88.68M | $70.49M | $68.81M | $48.16M |
EPS (Diluted) | $5.37 | $4.22 | $3.89 | $2.47 |
Total Assets | $1.69B | $1.35B | $1.18B | $1.04B |
Total Liabilities | $1.19B | $926.71M | $796.56M | $671.89M |
Cash & Equivalents | $303.78M | $148.32M | $173.12M | $46.03M |
Free Cash Flow OCF − CapEx | $53.98M | $77.14M | $93.96M | $978.00K |
Shares Outstanding | 15.51M | 15.70M | 16.18M | 17.69M |